Photo: Phil Ashley/Getty Images

Drug companies are increasingly trying to maximize their profits by creating generics to compete with their own brand-name products, Kaiser Health News reports.

Why it matters: "Authorized generics" can be just as profitable, if not more profitable, than the branded drug. They also can stifle competition from other generics, leading to higher prices for patients.

By the numbers: There are almost 1,200 authorized generics in the U.S., according to the FDA. Last year, there was about one new authorized generic a week.

  • For every $1 invested into an authorized generic, there's a return of $51, according to research firm Cutting Edge Information.

What they're saying: A spokesperson for PhRMA told KHN that authorized generics increase competition, which "reduces prices and results in significant cost savings."

The other side: They can “stave off generic competition and make sure that generics can’t get much of a foothold when they do get to market,” Robin Feldman, a professor at the University of California Hastings College of the Law, told KHN.

  • And because authorized generics often aren't subject to rebates, their net price could end up being higher than the net price of the original branded drug.

Go deeper: Reality check on Lilly's new, cheaper insulin

Go deeper

36 mins ago - Podcasts

Rural America has its own coronavirus problem

It's often easier to socially distance in rural America, but it can simultaneously be more challenging to get medical care.

Axios Re:Cap digs into the pandemic's urban-rural divide with microbiologist Amber Schmidtke, who has found that coronavirus-related morbidity is higher in many of Georgia's rural counties than in Atlanta.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3:30 p.m. ET: 12,373,722 — Total deaths: 556,863 — Total recoveries — 6,794,982Map.
  2. U.S.: Total confirmed cases as of 3:30 p.m. ET: 3,156,234 — Total deaths: 133,746 — Total recoveries: 969,111 — Total tested: 38,032,966Map.
  3. Public health: The U.S.'s new default strategy: herd immunity — 23 states and D.C. are mandating face coverings.
  4. ✈️ Travel: Delta CEO says Trump administration should issue mask mandate for air travelAirlines say air quality, cleanliness lower risk.

Biden and Trump point fingers over "buy American" proposals

Joe Biden at a campaign event in Wilmington, DE. Photo: Alex Wong/Getty Images

President Trump and Joe Biden are going back and forth over the former vice president's "buy American" economic proposal, which Trump claims Biden "plagiarized" from him.

Why it matters: Biden is directly challenging Trump and his "America First" agenda with the release of his latest plan, focused on economic recovery and re-investing in American manufacturing in the wake of the coronavirus pandemic.